Monday, February 6, 2023 | Back issues
Courthouse News Service Courthouse News Service

Drug Patents

PHILADELPHIA - Cephalon's purported patent for the sleep-disorder drug Provigil is invalid for a host of reasons, including failure to inform patent officials that French drugmaker Laboratoire Lafon was heavily involved in Provigil's development, a federal judge ruled.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.